Back
Biomarin Pharmaceutical Stock Price Chart
Sponsored
BMRN
Sponsored
Supercharge Your Portfolio with This High-Traction AI Startup
Learn More
Sell
32
BMRN
Biomarin Pharmaceutical
Last Price:
70.07
Seasonality Move:
6.37%
7 Day Trial
ALL ACCESS PASS
$
7
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn More- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight selling pressure.
Biomarin Pharmaceutical Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 69.94 | Buy |
20-day SMA: | 76.24 | Sell |
50-day SMA: | 83.37 | Sell |
200-day SMA: | 85.93 | Sell |
8-day EMA: | 70.89 | Sell |
20-day EMA: | 75.28 | Sell |
50-day EMA: | 80.39 | Sell |
200-day EMA: | 84.78 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.62 | Sell |
Relative Strength Index (14 RSI): | 27.28 | Sell |
Chaikin Money Flow: | -381118 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (70.26 - 88.12) | Sell |
Bollinger Bands (100): | (76.15 - 88.53) | Sell |
Biomarin Pharmaceutical Technical Analysis
Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 70.10 while BMRN 8-day simple moving average is 69.94, which is a Buy signal.
- The stock price of BMRN is 70.10 while Biomarin Pharmaceutical 20-day SMA is 76.24, which makes it a Sell.
- Biomarin Pharmaceutical 50-day simple moving average is 83.37 while BMRN share price is 70.10, making it a Sell technically.
- BMRN stock price is 70.10 and Biomarin Pharmaceutical 200-day simple moving average is 85.93, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Sell
32
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a Sell
The current Biomarin Pharmaceutical [BMRN] share price is $70.10. The Score for BMRN is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
13.35B
Price in USD:
70.10
Share Volume:
1.01M
Biomarin Pharmaceutical 52-Week Range
52-Week High:
99.56
52-Week Low:
67.75
Sell
32
Biomarin Pharmaceutical (BMRN)
is a Sell
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?
The Biomarin Pharmaceutical stock price is 70.10 USD today. -
Will BMRN stock go up or go down?
Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Biomarin Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 70.10 while BMRN 8-day exponential moving average is 70.89, which is a Sell signal.
- The stock price of BMRN is 70.10 while Biomarin Pharmaceutical 20-day EMA is 75.28, which makes it a Sell.
- Biomarin Pharmaceutical 50-day exponential moving average is 80.39 while BMRN share price is 70.10, making it a Sell technically.
- BMRN stock price is 70.10 and Biomarin Pharmaceutical 200-day simple moving average is 84.78, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
- BMRN Moving Average Covergence Divergence (MACD) indicator is -4.62, suggesting Biomarin Pharmaceutical is a Sell
- Biomarin Pharmaceutical Relative Strength Index (RSI) is 27.28, which suggest Biomarin Pharmaceutical is oversold
- The Bollinger Bands (25) for Biomarin Pharmaceutical is (70.26 - 88.12), which suggest Biomarin Pharmaceutical is a Sell
- The Bollinger Bands (100) for Biomarin Pharmaceutical is (76.15 - 88.53), which suggest Biomarin Pharmaceutical is a Sell
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.